{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:31:14Z","timestamp":1759483874843},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T00:00:00Z","timestamp":1097107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,7]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Proteinase 3 is the major autoantigen in patients with Wegener's granulomatosis. Earlier studies have shown that circulating leucocytes from patients with Wegener's granulomatosis show elevated proteinase 3 surface expression and mRNA levels. Wegener's granulomatosis patients also have increased levels of proteinase 3 in plasma. A single nucleotide polymorphism (SNP) (\u2212\u2003564\u2003A\/G SNP) in the promoter region has been associated with disease. This SNP introduces a new potential Sp1 transcription factor binding site that may be responsible for the observed up-regulated expression of proteinase 3. To investigate this a 740 base pair long region of the promoter was cloned from genomic DNA. The disease-associated \u2212\u200a564\u2003A\/G, as well as a control \u2212\u200a621\u2003A\/G exchange, were introduced by polymerase chain reaction mutagenesis and cloned into a luciferase reporter vector. Endogenous expression levels of proteinase 3 mRNA and promoter activity of the cloned constructs were measured in three myeloid cell lines, HL-60, U937 and NB-4, and in epithelial HeLa cells. The results demonstrate a good correlation between the endogenous proteinase 3 mRNA expression and the promoter activity, as judged by luciferase activity. However, no significant differences in activity between the wild-type, polymorphic and the mutated control variant were found. In conclusion, the \u2212\u200a564\u2003A\/G polymorphism is not responsible for the increased expression levels seen in myeloid cells from patients with Wegener's granulomatosis.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2004.02608.x","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T11:44:23Z","timestamp":1098272663000},"page":"266-270","source":"Crossref","is-referenced-by-count":13,"title":["The \u2212\u200a564\u2003A\/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity"],"prefix":"10.1093","volume":"138","author":[{"given":"K","family":"PIETERS","sequence":"first","affiliation":[{"name":"Department of Haematology, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5","family":"PETTERSSON","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"GULLBERG","sequence":"additional","affiliation":[{"name":"Department of Haematology, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"HELLMARK","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,10,20]]},"reference":[{"key":"2022010901430330600_b1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0403134","article-title":"20 years with ANCA (antineutrophil cytoplasmic autoantibodies): from seromarker to a major pathogenic player in vasculitis","volume":"74","author":"Hellmich","year":"2003","journal-title":"J Leukoc Biol"},{"key":"2022010901430330600_b2","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener's granulomatosis and anticytoplasmic antibodies","volume":"149","author":"Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"key":"2022010901430330600_b3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int"},{"key":"2022010901430330600_b4","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496","article-title":"Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules","volume":"94","author":"Witko-Sarsat","year":"1999","journal-title":"Blood"},{"key":"2022010901430330600_b5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1994.tb06518.x","article-title":"Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo","volume":"95","author":"Csernok","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2022010901430330600_b6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2022010901430330600_b7","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2022010901430330600_b8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V98.5.1448","article-title":"Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation","volume":"98","author":"Ben-Smith","year":"2001","journal-title":"Blood"},{"key":"2022010901430330600_b9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2249.2000.01228.x","article-title":"Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils","volume":"121","author":"Yang","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022010901430330600_b10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-1759(94)90364-6","article-title":"Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma","volume":"175","author":"Baslund","year":"1994","journal-title":"J Immunol Meth"},{"key":"2022010901430330600_b11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/art.1780370116","article-title":"Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa","volume":"37","author":"Henshaw","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2022010901430330600_b12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2249.2003.02083.x","article-title":"Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission","volume":"131","author":"Ohlsson","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2022010901430330600_b13","first-page":"634A","article-title":"Increased monocyte transcription of the proteinase 3 gene, cause or consequence of ANCA associated vasculitis?","volume":"14","author":"Ohlsson","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2022010901430330600_b14","doi-asserted-by":"crossref","first-page":"32392","DOI":"10.1074\/jbc.271.50.32392","article-title":"Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element","volume":"271","author":"Sturrock","year":"1996","journal-title":"J Biol Chem"},{"key":"2022010901430330600_b15","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1073\/pnas.97.4.1601","article-title":"Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells","volume":"97","author":"Lutz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010901430330600_b16","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood.V97.8.2449","article-title":"Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid","volume":"97","author":"Lutz","year":"2001","journal-title":"Blood"},{"key":"2022010901430330600_b17","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1046\/j.1523-1755.2000.00430.x","article-title":"Proteinase 3 gene polymorphisms and Wegener's granulomatosis","volume":"58","author":"Gencik","year":"2000","journal-title":"Kidney Int"},{"key":"2022010901430330600_b18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/clim.2002.5206","article-title":"63 G\/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO\u2013ANCA-associated vasculitis","volume":"103","author":"Reynolds","year":"2002","journal-title":"Clin Immunol"},{"key":"2022010901430330600_b19","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1016\/S0021-9258(18)48159-8","article-title":"Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colony-stimulating factor","volume":"262","author":"Morishita","year":"1987","journal-title":"J Biol Chem"},{"key":"2022010901430330600_b20","first-page":"277","article-title":"Site-directed mutagenesis by double polymerase chain reaction: megaprimer method","volume-title":"Methods in molecular biology","author":"Barik","year":"1993"},{"key":"2022010901430330600_b21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0301-472X(02)00806-8","article-title":"Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream","volume":"30","author":"Ginzinger","year":"2002","journal-title":"Exp Hematol"},{"key":"2022010901430330600_b22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbrc.2003.10.067","article-title":"AM-1, PU. 1, and Sp3 regulate expression of human bactericidal\/permeability-increasing protein","volume":"311","author":"Lennartsson","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2022010901430330600_b23","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1074\/jbc.271.6.2972","article-title":"Biosynthesis and processing of proteinase 3 in U937 cells","volume":"271","author":"Rao","year":"1996","journal-title":"J Biol Chem"},{"key":"2022010901430330600_b24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood.V81.2.475.475","article-title":"Regulation of myeloblastin messenger RNA expression in myeloid leukemia cells treated with all-trans retinoic acid","volume":"81","author":"Labbaye","year":"1993","journal-title":"Blood"},{"key":"2022010901430330600_b25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(89)90752-6","article-title":"Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells","volume":"59","author":"Bories","year":"1989","journal-title":"Cell"},{"key":"2022010901430330600_b26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-5793(95)01073-N","article-title":"Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool","volume":"374","author":"Halbwachs-Mecarelli","year":"1995","journal-title":"FEBS Lett"},{"key":"2022010901430330600_b27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1006\/bbrc.1994.1568","article-title":"Myeloblastin\/proteinase 3 belongs to the set of negatively regulated primary response genes expressed during in vitro myeloid differentiation","volume":"200","author":"Chen","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2022010901430330600_b28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ndt\/gfh025","article-title":"No association of G-463A myeloperoxidase gene polymorphism with MPO\u2013ANCA-associated vasculitis","volume":"19","author":"Fiebeler","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2022010901430330600_b29","doi-asserted-by":"crossref","first-page":"14412","DOI":"10.1074\/jbc.271.24.14412","article-title":"An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element","volume":"271","author":"Piedrafita","year":"1996","journal-title":"J Biol Chem"},{"key":"2022010901430330600_b30","doi-asserted-by":"crossref","first-page":"20406","DOI":"10.1016\/S0021-9258(18)54937-1","article-title":"Promoter activity and distance constraints of one versus two Sp1 binding sites","volume":"266","author":"Segal","year":"1991","journal-title":"J Biol Chem"},{"key":"2022010901430330600_b31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","article-title":"Proteinase 3, Wegener's autoantigen: from gene to antigen","volume":"69","author":"Van Der Geld","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2022010901430330600_b32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.leu.2402514","article-title":"Functional activity of three distinct myeloperoxidase (MPO) promoters in human myeloid cells","volume":"16","author":"Lin","year":"2002","journal-title":"Leukemia"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2004.02608.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/138\/2\/266\/42081987\/j.1365-2249.2004.02608.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/138\/2\/266\/42081987\/j.1365-2249.2004.02608.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T16:27:55Z","timestamp":1682785675000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/138\/2\/266\/6439830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,7]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,10,20]]},"published-print":{"date-parts":[[2004,10,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02608.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,10,7]]}}}